Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV002247908 | SCV002517216 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003101328 | SCV003280102 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2022-04-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004045187 | SCV003877665 | uncertain significance | Cardiovascular phenotype | 2023-02-27 | criteria provided, single submitter | clinical testing | The c.203G>C (p.R68P) alteration is located in exon 2 (coding exon 2) of the JAG1 gene. This alteration results from a G to C substitution at nucleotide position 203, causing the arginine (R) at amino acid position 68 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |